Display Settings:

Format

Send to:

Choose Destination

    Ann Intern Med. 1982 Jan;96(1):58-60.

    Hepatic veno-occlusive disease caused by 6-thioguanine.

    Gill RA, Onstad GR, Cardamone JM, Maneval DC, Sumner HW.

    Clinically reversible veno-occlusive disease of the liver developed in a 23-year-old man with acute lymphocytic leukemia after 10 months of maintenance therapy with 6-thioguanine. Serial liver biopsies showed the development and resolution of intense sinusoidal engorgement. Although this disease was clinically reversible, some subintimal fibrosis about the terminal hepatic veins persisted. This case presented a unique opportunity to observe the histologic features of clinically reversible hepatic veno-occlusive disease over time, and may be the first case of veno-occlusive related solely to 6-thioguanine.

    PMID: 7053705 [PubMed - indexed for MEDLINE]

    LinkOut - more resources

    Full Text Sources:

    Molecular Biology Databases:

    Supplemental Content

    Patient drug information

    • Thioguanine (Thioguanine Tabloid®)

      Your doctor has ordered the drug thioguanine to help treat your illness. The drug can be taken by mouth in tablet form.